TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Novo Nordisk Scandinavia AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
171,405
|
161,663
|
104,847 |
| Financial expenses |
129
|
36
|
8 |
| Earnings before taxes |
6,760
|
6,443
|
4,599 |
| EBITDA |
6,187
|
5,996
|
4,492 |
| Total assets |
33,584
|
43,942
|
40,204 |
| Current assets |
33,431
|
43,919
|
40,171 |
| Current liabilities |
17,630
|
28,822
|
27,378 |
| Equity capital |
12,269
|
11,476
|
8,949 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
123
|
110
|
115 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
36.5%
|
26.1%
|
22.3% |
| Turnover per employee |
1,394
|
1,470
|
912 |
| Profit as a percentage of turnover |
3.9%
|
4.0%
|
4.4% |
| Return on assets (ROA) |
20.5%
|
14.7%
|
11.5% |
| Current ratio |
189.6%
|
152.4%
|
146.7% |
| Return on equity (ROE) |
55.1%
|
56.1%
|
51.4% |
| Change turnover |
15,239
|
56,511
|
20,697 |
| Change turnover % |
10%
|
54%
|
25% |
| Chg. No. of employees |
13
|
-5
|
9 |
| Chg. No. of employees % |
12%
|
-4%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.